Our associates have a combined 75 years of experience in all areas of healthcare, from pharmaceuticals to devices to providers and payors.
EXECUTIVE TEAM
Erik Verhoef, President and CEO
Erik founded Seagrove Partners in 2016 after spending 9 years at Tandem Diabetes Care (NASDAQ: TNDM), where he headed up Strategy, Business Development, Marketing and Market Research, leading to the design and commercial launch of t:slim, the award-winning insulin pump. He played a pivotal role in helping the company raise 5 rounds of venture funding and was part of the core team that completed Tandem’s initial public offering — one of the most successful issuances in medical device history. Prior to Tandem, Erik held roles in commercial analytics and marketing at Biosite, Bristol Myers-Squibb, and GlaxoSmithKline. Additionally, he was a widely published healthcare equity research analyst at Susquehanna Financial and William Blair. Erik started his career in healthcare consulting at Tiber Group, Campbell Alliance and the Advisory Board Company. He holds an MBA in Finance and a certificate in Health Services Management from Duke University and a BA in European History from Northwestern University. He is currently completing coursework in Molecular Biology at the Massachusetts Institute of Technology. Erik resides in San Diego, CA.
Maria Verhoef, Senior Vice President
Maria joined Seagrove Partners in 2018 and focuses on syndicated research (diabetes and oncology) and client services. Previously, she was a Senior Director at Aries Pharmaceuticals and held positions of increasing responsibility at Arena Pharmaceuticals, Amylin Pharmaceuticals, Bristol Myers-Squibb, and GlaxoSmithKline. Previous to the pharmaceutical industry, Maria worked in investment banking at JP Morgan and First Chicago. Maria holds an MBA in finance from Duke University and AB in History from Cornell University. She resides in San Diego, CA.